Drug safety on trial

The price of innovation: new estimates of drug development costs

Joseph A. DiMasi, Ronald W. Hansen, Henry G. Grabowski · Journal of Health Economics · 2003 · 4.3K citations

Economics, Pharmaceutical Innovation, Applied Economics +11

Failing the Public Health — Rofecoxib, Merck, and the FDA

Eric J. Topol · New England Journal of Medicine · 2004 · 592 citations · Full text

Health Politics, Pharmacotherapy, Market Rofecoxib +24

Attitudinal survey of voluntary reporting of adverse drug reactions

Eland, Belton, van Adrianus Grootheest et al. · British Journal of Clinical Pharmacology · 1999 · 256 citations · Full text